CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) (“Dicerna”), announced today the pricing of its underwritten registered public offering of 2,750,000 shares of its common stock at a price to the public of $17.75 per share. Closing of the offering is expected to occur on May 27, 2015, subject to customary closing conditions. Dicerna also granted the underwriters a 30-day option to purchase up to 412,500 additional shares of common stock.
Help employers find you! Check out all the jobs and post your resume.
